Infections during mobilizing chemotherapy and following autologous stem cell transplantation

Bone Marrow Transplantation

Volumn 28, Issue 12, 2001, Pages 1129-1134

  Toor, A A ^a   van Burik, J A ^a   Weisdorf, D J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Autologous stem cell transplant; Infections; Mobilizing chemotherapy

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; BUSULFAN; CARBOPLATIN; CARMUSTINE; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; METRONIDAZOLE; MITOXANTRONE; PENICILLIN V POTASSIUM; THIOTEPA; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; BACTEREMIA; BLOOD CULTURE; CANDIDA GLABRATA; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIARRHEA; FEMALE; FUNGUS ISOLATION; GASTROINTESTINAL DISEASE; GRAM NEGATIVE BACTERIUM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYCOSIS; NEUTROPENIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TIME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BACTEREMIA; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; INFECTION; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 0035694517     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703307     Document Type: Article

References (20)

1. Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma
2. High-dose chemotherapy followed by autologous blood cell transplantation: A safe and effective outpatient approach
3. Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma
4. Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies
5. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b
6. Expression of CD11b/CD18 on neutrophils after consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell transplantation
7. Candida infections in bone marrow transplant recipients
8. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
9. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial
10. High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients
11. Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer
12. Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation
13. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: A randomized, controlled trial
14. Etiology and outcome of diarrhea after marrow transplantation: A prospective study
15. Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation
16. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation
17. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF
18. Cytomegaloviremia after autografting for leukemia: Clinical significance and lack of effect on engraftment
19. Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: No need for surveillance
20. Isolation of viruses from stools in stem cell transplant recipients: A prospective surveillance study